RAD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.692800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.836600E-01
Normal-vs-Stage2
5.566600E-01
Normal-vs-Stage3
1.096030E-01
Normal-vs-Stage4
8.630800E-01
Stage1-vs-Stage2
1.918560E-01
Stage1-vs-Stage3
5.840200E-02
Stage1-vs-Stage4
8.918000E-01
Stage2-vs-Stage3
2.611200E-01
Stage2-vs-Stage4
3.665400E-01
Stage3-vs-Stage4
1.756040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.736800E-01
Normal-vs-AfricanAmerican
8.734000E-01
Normal-vs-Asian
4.563200E-01
Caucasian-vs-AfricanAmerican
7.092000E-01
Caucasian-vs-Asian
7.044800E-01
AfricanAmerican-vs-Asian
5.258000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.633800E-01
Normal-vs-Female
3.043000E-01
Male-vs-Female
4.076000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.711800E-01
Normal-vs-Age(41-60Yrs)
6.827400E-01
Normal-vs-Age(61-80Yrs)
4.765800E-01
Normal-vs-Age(81-100Yrs)
2.257400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.310000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.593400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.584400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.698400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.774300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.792600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.629800E-01
Normal-vs-Daily Drinker
4.161600E-01
Normal-vs-Weekly Drinker
9.704200E-01
Normal-vs-Occasional Drinker
8.922200E-01
Normal-vs-Social Drinker
8.685000E-01
Non Drinker-vs-Daily Drinker
4.609000E-01
Non Drinker-vs-Weekly Drinker
1.591210E-01
Non Drinker-vs-Occasional Drinker
3.021500E-02
Non Drinker-vs-Social Drinker
1.019180E-01
Daily Drinker-vs-Weekly Drinker
3.186000E-01
Daily Drinker-vs-Occasional Drinker
2.093400E-01
Daily Drinker-vs-Social Drinker
1.935590E-01
Weekly Drinker-vs-Occasional Drinker
8.364000E-01
Weekly Drinker-vs-Social Drinker
9.296000E-01
Occasional Drinker-vs-Social Drinker
7.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.051800E-01
Normal-vs-Grade 2
7.786800E-01
Normal-vs-Grade 3
7.769000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.393800E-01
Grade 1-vs-Grade 3
5.357800E-01
Grade 1-vs-Grade 4
8.051800E-01
Grade 2-vs-Grade 3
9.294200E-01
Grade 2-vs-Grade 4
7.786800E-01
Grade 3-vs-Grade 4
7.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.849800E-01
Normal-vs-NonDiabetic
6.902600E-01
Diabetic-vs-NonDiabetic
1.531780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.234400E-01
Normal-vs-NoPancreatitis
6.271800E-01
Pancreatitis-vs-NoPancreatitis
9.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.260200E-01
Normal-vs-N1
5.790800E-01
N0-vs-N1
3.702800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.381800E-01
Normal-vs-TP53-NonMutant
8.851200E-01
TP53-Mutant-vs-TP53-NonMutant
8.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
